NCT04075721 · MORE INFO

Limitations, agreements, and source contact

First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone · Source last updated 2023-03-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: false
restrictive Agreement: false

limitations And Caveats

description: Part B was not conducted as the study was early discontinued due to lack of participant's recruitment into Part A before Part A reached its primary objective.

point Of Contact

email: service@emdgroup.com
organization: Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
phone: +49-6151-72-5200
title: Communication Center

Complete source fields

certain Agreement

pi Sponsor Employee: false
restrictive Agreement: false

limitations And Caveats

description: Part B was not conducted as the study was early discontinued due to lack of participant's recruitment into Part A before Part A reached its primary objective.

point Of Contact

email: service@emdgroup.com
organization: Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
phone: +49-6151-72-5200
title: Communication Center

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice